184 related articles for article (PubMed ID: 22572079)
21. Dose-volume parameters predict for the development of chest wall pain after stereotactic body radiation for lung cancer.
Mutter RW; Liu F; Abreu A; Yorke E; Jackson A; Rosenzweig KE
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1783-90. PubMed ID: 21868173
[TBL] [Abstract][Full Text] [Related]
22. Radiation-induced changes of brain tissue after radiosurgery in patients with arteriovenous malformations: correlation with dose distribution parameters.
Levegrün S; Hof H; Essig M; Schlegel W; Debus J
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):796-808. PubMed ID: 15183483
[TBL] [Abstract][Full Text] [Related]
23. Dosimetric Factors Related to Radiation Necrosis After 5-Fraction Radiosurgery for Patients With Resected Brain Metastases.
Tanenbaum DG; Buchwald ZS; Jhaveri J; Schreibmann E; Switchenko JM; Prabhu RS; Chowdhary M; Abugideiri M; Pfister NT; Eaton B; Kahn SE; Olson JJ; Shu HG; Crocker IR; Curran WJ; Patel KR
Pract Radiat Oncol; 2020; 10(1):36-43. PubMed ID: 31586666
[TBL] [Abstract][Full Text] [Related]
24. Stereotactic body radiation therapy for benign spine tumors: is dose de-escalation appropriate?
Kalash R; Glaser SM; Flickinger JC; Burton S; Heron DE; Gerszten PC; Engh JA; Amankulor NM; Vargo JA
J Neurosurg Spine; 2018 Aug; 29(2):220-225. PubMed ID: 29799334
[TBL] [Abstract][Full Text] [Related]
25. Esophageal Dose Tolerance in Patients Treated With Stereotactic Body Radiation Therapy.
Nuyttens JJ; Moiseenko V; McLaughlin M; Jain S; Herbert S; Grimm J
Semin Radiat Oncol; 2016 Apr; 26(2):120-8. PubMed ID: 27000508
[TBL] [Abstract][Full Text] [Related]
26. RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1-3) spine metastases: phase 2 results.
Ryu S; Pugh SL; Gerszten PC; Yin FF; Timmerman RD; Hitchcock YJ; Movsas B; Kanner AA; Berk LB; Followill DS; Kachnic LA
Pract Radiat Oncol; 2014; 4(2):76-81. PubMed ID: 24890347
[TBL] [Abstract][Full Text] [Related]
27. Dose-Volume Tolerance of the Brain and Predictors of Radiation Necrosis After 3-Fraction Radiosurgery for Brain Metastases: A Large Single-Institutional Analysis.
Upadhyay R; Ayan AS; Jain S; Klamer BG; Perlow HK; Zoller W; Blakaj DM; Beyer S; Grecula J; Arnett A; Thomas E; Chakravarti A; Raval RR; Palmer JD
Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):275-284. PubMed ID: 37574170
[TBL] [Abstract][Full Text] [Related]
28. Effect of Tumor Location and Dosimetric Predictors for Chest Wall Toxicity in Single-Fraction Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.
Manyam BV; Videtic GMM; Verdecchia K; Reddy CA; Woody NM; Stephans KL
Pract Radiat Oncol; 2019 Mar; 9(2):e187-e195. PubMed ID: 30529796
[TBL] [Abstract][Full Text] [Related]
29. Significance of target location relative to the depth from the brain surface and high-dose irradiated volume in the development of brain radionecrosis after micromultileaf collimator-based stereotactic radiosurgery for brain metastases.
Ohtakara K; Hayashi S; Nakayama N; Ohe N; Yano H; Iwama T; Hoshi H
J Neurooncol; 2012 May; 108(1):201-9. PubMed ID: 22392126
[TBL] [Abstract][Full Text] [Related]
30. Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery.
Blonigen BJ; Steinmetz RD; Levin L; Lamba MA; Warnick RE; Breneman JC
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):996-1001. PubMed ID: 19783374
[TBL] [Abstract][Full Text] [Related]
31. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
[TBL] [Abstract][Full Text] [Related]
32. Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases.
Wang CJ; Christie A; Lin MH; Jung M; Weix D; Huelsmann L; Kuhn K; Meyer J; Desai N; Kim DWN; Pedrosa I; Margulis V; Cadeddu J; Sagalowsky A; Gahan J; Laine A; Xie XJ; Choy H; Brugarolas J; Timmerman R; Hannan R
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):91-100. PubMed ID: 28587057
[TBL] [Abstract][Full Text] [Related]
33. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
Loo M; Pin Y; Thierry A; Clavier JB
Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
[TBL] [Abstract][Full Text] [Related]
34. Five-Year Outcomes of a Phase 1 Dose-Escalation Study Using Stereotactic Body Radiosurgery for Patients With Low-Risk and Intermediate-Risk Prostate Cancer.
Zelefsky MJ; Kollmeier M; McBride S; Varghese M; Mychalczak B; Gewanter R; Garg MK; Happersett L; Goldman DA; Pei I; Lin M; Zhang Z; Cox BW
Int J Radiat Oncol Biol Phys; 2019 May; 104(1):42-49. PubMed ID: 30611838
[TBL] [Abstract][Full Text] [Related]
35. Esophagus toxicity after stereotactic and hypofractionated radiotherapy for central lung tumors: Normal tissue complication probability modeling.
Duijm M; Tekatli H; Oomen-de Hoop E; Verbakel W; Schillemans W; Slotman BJ; Senan S; Nuyttens JJ
Radiother Oncol; 2018 May; 127(2):233-238. PubMed ID: 29478763
[TBL] [Abstract][Full Text] [Related]
36. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
[TBL] [Abstract][Full Text] [Related]
37. Spinal cord constraints in the era of high-precision radiotherapy : Retrospective analysis of 62 spinal/paraspinal lesions with possible infringements of spinal cord constraints within a minimal volume.
Zschaeck S; Wust P; Graf R; Wlodarczyk W; Schild R; Thieme AH; Weihrauch M; Budach V; Ghadjar P
Strahlenther Onkol; 2017 Jul; 193(7):561-569. PubMed ID: 28466154
[TBL] [Abstract][Full Text] [Related]
38. Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy.
Kim TH; Cho KH; Pyo HR; Lee JS; Han JY; Zo JI; Lee JM; Hong EK; Choi IJ; Park SY; Shin KH; Kim DY; Kim JY
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):995-1002. PubMed ID: 15990000
[TBL] [Abstract][Full Text] [Related]
39. Acute and Late Esophageal Toxicity After SABR to Thoracic Tumors Near or Abutting the Esophagus.
Sodji QH; Ko R; von Eyben R; Owen SG; Capaldi DPI; Bush K; Binkley MS; Alrowais F; Pickthorn B; Maxim PG; Gensheimer MF; Diehn M; Loo BW
Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1144-1153. PubMed ID: 34942312
[TBL] [Abstract][Full Text] [Related]
40. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies.
Goodman KA; Wiegner EA; Maturen KE; Zhang Z; Mo Q; Yang G; Gibbs IC; Fisher GA; Koong AC
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):486-93. PubMed ID: 20350791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
